GENE ONLINE|News &
Opinion
Blog

2025-11-07|

Xinjiang Medical University Researchers Identify New Keratinocyte Subpopulation Linked to Early-Stage HPV-Positive Cervical Cancer

by GOAI
Share To

Researchers at Xinjiang Medical University have identified a previously unknown keratinocyte subpopulation associated with early-stage cervical squamous cell carcinoma (CESC) linked to human papillomavirus (HPV) infection. The study utilized advanced single-cell RNA sequencing (scRNA-seq) and multiplex immunohistochemistry (mIHC) techniques to analyze the cellular and molecular composition of HPV-positive cervical tumors. This discovery sheds light on potential mechanisms driving the progression of early cervical cancer.

The research team conducted a detailed mapping of HPV-positive tumor samples, focusing on cellular interactions and gene expression patterns within the tumor microenvironment. Through scRNA-seq, they were able to isolate specific cell populations and identify unique molecular markers associated with this newly discovered keratinocyte subpopulation. Complementary mIHC analysis further validated their findings by visualizing these cells within tissue samples. The study highlights the importance of understanding cellular diversity in HPV-related cancers, offering new insights into the biology of early-stage CESC.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 7, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top